• Forum
  • Aktiemarkeder
    • MarkederRealtidskurser, indekser og markedsudvikling
    • BørskalenderKommende resultater, noteringer og virksomhedsbegivenheder
    • UdbyttekalenderKommende og tidligere udbytter
  • Selskaber
    • SelskaberGennemse og filtrer den fulde liste over børsnoterede selskaber
    • OpdagInspiration til din næste investering
    • BørsnoteringerNye noteringer og kommende børsintroduktioner
    • Invitationer til generalforsamlingerDatoer for generalforsamlinger og aktionærinformation
  • Aktieanalyse
    • ResearchEkspertaktieanalyse og anbefalinger
    • ArtiklerNyheder, indsigter og markedskommentarer
    • inderesTVVideocenter for aktieanalyse, forskning og ekspertkommentarer
    • TransskriptionerFuldstændige udskrifter af resultatopkald og investormøder
    • AktieoversigtSammenlign nøgletal og udvikling på tværs af flere aktier
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer

Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.

Selskabsmeddelelse

BrainCool receives an order for 10 demo versions of BrainCool™ System from ZOLL®

BrainCool
Download udgivelse

BrainCool AB (publ) announces today that the company has received an order from its commercialization partner ZOLL® for 10 demo versions of BrainCool™ System. The order value is SEK 1.7 million, and the equipment will be delivered in the first quarter of 2025. BrainCool™ System offers precision temperature management of the body, for example, to improve survival and reduce permanent disability in people suffering from sudden cardiac arrest or stroke.

The demo version of BrainCool™ System, Table Top, is a portable simulation equipment for real-life demonstration of the system’s key benefits in precision cooling of patients suffering from stroke or cardiac arrest. 
 
“Table Top is a powerful tool for promoting BrainCool™ System to new customers. The order of ten units from ZOLL® confirms our commercialization partner’s commitment to making the BrainCool™ System the leading cooling system on the market,” said Jon Berg, CEO of BrainCool.
 
The ZOLL® sales and marketing team will use Table Tops to showcase the key benefits of BrainCool™ System. Table Top is a highly flexible and efficient tool that is portable and easy to use, whereas demonstrating the complete BrainCool™ System to potential customers can be cumbersome and time-consuming. Training and practice on the BrainCool™ System can be conducted on a Table Top, including handling various alarm and alert functions. Table Top is also ideal for demonstrations at fairs and events within the medical sector.

Contact
For more information
Jon Berg - CEO
+46 722 50 91 19
E-mail: jon.berg@braincool.se

About Us
BrainCool AB (publ) is an innovative medical device company that develops, markets, and sells leading medical cooling systems for indications and areas with significant medical benefits within the healthcare sector. BrainCool AB (publ) is based in Lund, Sweden, and its share is listed on Nasdaq First North Growth Market, named “BRAIN”.
Eminova Fondkommission AB is the company’s Certified Adviser.

Attachments
BrainCool receives an order for 10 demo versions of BrainCool™ System from ZOLL®